Management of eclampsia in the prehospital setting

Rodríguez, Alonso A. Mateos; Vellisca, Miguel Ángel Benito

doi:10.1136/emj.2007.047209

Cited by 2 publications

(3 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Osim Propafenona, prehospitalno je nedostupan i Magnesium sulfat. To je lek koji se koristi u trudnoći kod preeklampsije, eklampsije ili intoksikacije kako bi se prevenirali konvulzivni napadi [41]. Preporučuje se i kod Torsades de pointes udružene sa prolongiranim Q-T intervalom [42].…”

Section: Prehospitalno Nedostupni Lekovi Sa Liste Dunclassified

“…[25 40] Adenosine acts faster, has shorter effect, is safer for use in pregnancy, has less adverse events than other antiarrhythmic drugs. [38,41,39] Gausche and associates published the study in 1994 showing Adenosine effective and safe to convert supraventricular tachycardia in prehospital use by paramedics. [42] This means that there are no limits for the procurement of the drug and its pre-hospital use by urgent medicine physicians.…”

Section: Unregistered Drugs In Serbia Not Present On Anymentioning

confidence: 99%

See 1 more Smart Citation

Can we treat urgent medical conditions without adequate drugs?

Jokšić-Mazinjanin¹,

Vasović²,

Gojković³

et al. 2022

Timočki medicinski glasnik

View full text Add to dashboard Cite

Emergency Medicine does not represent a simple collection of various medical conditions, but rather an urgent approach to life threatening conditions. This urgent approach progresses as fast as the science in medicine does. Modern protocols for treatment of injured and ill patients are introduced, demanding more and more knowledge and skills as well as more modern equipment and wider spectrum of drugs. However, innovations are not followed by changes within the lists of medications set by National Health Insurance Fund of Serbia (NHIFS). Paper describes drugs necessary for adequate pre-hospital treatment that are not available to the physicians due to administrative barriers. On one hand, there are drugs from B list that are necessary for treatment, and are approved for use by NHIFS at hospital level only. The use of any of these drugs at pre-hospital level may lead to severe penalties to the physician in case of complications or adverse reactions in a patient following the treatment. On the other hand, there are drugs from D list which are also necessary for the urgent treatment of patients with life threatening conditions, according to latest recommendations. These drugs may be applied at pre-hospital level, but their procurement is complicated due to NHIFS regulations and that's why some of them may rarely be used (Propafenone and Magnesium sulfate). We particularly emphasize that one of the most effective drugs for the conversion of heart rhythm, Adenosine (6 mg/ml and 10mg/ml ampoule), is not registered in the Republic of Serbia and therefore cannot be used at pre-hospital level. Through these exclusive administrative barriers adequate treatment is rendered impossible while the system of urgent treatment of patients with life threatening conditions at pre-hospital level is degraded.

show abstract

Section: Prehospitalno Nedostupni Lekovi Sa Liste Dunclassified

Section: Unregistered Drugs In Serbia Not Present On Anymentioning

confidence: 99%